Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR183 | P32249 | 15/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.63 |
| ▸ | ATXN2 | Q99700 | 1/20 | 0.63 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16599835 | 1.00 | GPR183 (1.00) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL16600221 | 0.95 | GPR183 (0.91) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL17853006 | 0.93 | GPR183 (0.87) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL17853012 | 0.88 | GPR183 (0.79) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL17856076 | 0.86 | GPR183 (1.00) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL16600067 | 0.86 | GPR183 (1.00) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL17838634 | 0.86 | GPR183 (1.00) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL16599808 | 0.85 | GPR183 (0.88) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL17853000 | 0.82 | GPR183 (0.81) | GPR183ENPP2ATXN2HRH4HRH3 | |
| SCHEMBL16599449 | 0.81 | HRH4 (0.67) | GPR183HRH4HRH3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015048567-A1 | SPIROCYCLIC EBI2 MODULATORS | SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) | 2015-04-02 | — | — | WO | disclosed |